265 related articles for article (PubMed ID: 19519503)
1. From nature to drug discovery: the indole scaffold as a 'privileged structure'.
de Sá Alves FR; Barreiro EJ; Fraga CA
Mini Rev Med Chem; 2009 Jun; 9(7):782-93. PubMed ID: 19519503
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress in Biological Activities of Indole and Indole Alkaloids.
Singh TP; Singh OM
Mini Rev Med Chem; 2018; 18(1):9-25. PubMed ID: 28782480
[TBL] [Abstract][Full Text] [Related]
3. Cyclohepta[b]indoles: A Privileged Structure Motif in Natural Products and Drug Design.
Stempel E; Gaich T
Acc Chem Res; 2016 Nov; 49(11):2390-2402. PubMed ID: 27709885
[TBL] [Abstract][Full Text] [Related]
4. Spirooxindoles as Potential Pharmacophores.
Panda SS; Jones RA; Bachawala P; Mohapatra PP
Mini Rev Med Chem; 2017; 17(16):1515-1536. PubMed ID: 29056096
[TBL] [Abstract][Full Text] [Related]
5. Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents.
Yu B; Zheng YC; Shi XJ; Qi PP; Liu HM
Anticancer Agents Med Chem; 2016; 16(10):1315-24. PubMed ID: 26522954
[TBL] [Abstract][Full Text] [Related]
6. Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.
Chadha N; Silakari O
Eur J Med Chem; 2017 Jul; 134():159-184. PubMed ID: 28412530
[TBL] [Abstract][Full Text] [Related]
7. Recognition of privileged structures by G-protein coupled receptors.
Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Li Z; Mu Y; Xu B; Shen Z
Eur J Med Chem; 2015 Jan; 90():394-405. PubMed ID: 25461330
[TBL] [Abstract][Full Text] [Related]
9. Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.
Gul W; Hamann MT
Life Sci; 2005 Dec; 78(5):442-53. PubMed ID: 16236327
[TBL] [Abstract][Full Text] [Related]
10. Natural product derived privileged scaffolds in drug discovery.
Davison EK; Brimble MA
Curr Opin Chem Biol; 2019 Oct; 52():1-8. PubMed ID: 30682725
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Mattsson C; Svensson P; Boettcher H; Sonesson C
Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the Chemistry of the Indole Heterocycle to Drive Discoveries in Biology and Medicine.
Norwood VM; Huigens RW
Chembiochem; 2019 Sep; 20(18):2273-2297. PubMed ID: 30609199
[TBL] [Abstract][Full Text] [Related]
14. 2-Arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activity.
Lal S; Snape TJ
Curr Med Chem; 2012; 19(28):4828-37. PubMed ID: 22830349
[TBL] [Abstract][Full Text] [Related]
15. Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.
Cooper AG; MacDonald C; Glass M; Hook S; Tyndall JDA; Vernall AJ
Eur J Med Chem; 2018 Feb; 145():770-789. PubMed ID: 29407590
[TBL] [Abstract][Full Text] [Related]
16. Synthetic analogs of indole-containing natural products as inhibitors of sortase A and isocitrate lyase.
Lee YJ; Han YR; Park W; Nam SH; Oh KB; Lee HS
Bioorg Med Chem Lett; 2010 Dec; 20(23):6882-5. PubMed ID: 21035332
[TBL] [Abstract][Full Text] [Related]
17. A review on recent developments of indole-containing antiviral agents.
Zhang MZ; Chen Q; Yang GF
Eur J Med Chem; 2015 Jan; 89():421-41. PubMed ID: 25462257
[TBL] [Abstract][Full Text] [Related]
18. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.
Nirogi RV; Badange R; Kambhampati R; Chindhe A; Deshpande AD; Tiriveedhi V; Kandikere V; Muddana N; Abraham R; Khagga M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7431-5. PubMed ID: 23141912
[TBL] [Abstract][Full Text] [Related]
20. Indoles - A promising scaffold for drug development.
Sravanthi TV; Manju SL
Eur J Pharm Sci; 2016 Aug; 91():1-10. PubMed ID: 27237590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
